Patient Demographics: G.G and H.T are both 16 year old Caucasian females. Clinical Presentation: G.G and H.T were both referred for investigation of primary amenorrhea. Neither girl had a particular phenotype, the onset of thelarche was age appropriate, at the age of 12 years. At presentation both had completed puberty with breast Tanner stage V, pubic hair stage V, both had an absence of menses. Relevant Past History: G.G has a background of Type 1 DM, diagnosed 1 year to presentation with excellent control. H.T had presented to her general practitioner 2 years prior with PCOS like symptoms, and was commenced on the contraceptive pill. Neither of the girls has a family history of late puberty. Evaluation: G.G had an age appropriate hormonal level and went on to have a pelvic U/S and subsequent MRI, with a finding of uterine didelphys with two separate endometrial cavities, two cervical canals, both distended due to haematocolpos, associated unilateral kidney hypoplasia. H.T had age appropriate hormonal levels, underwent a pelvic U/S and MRI, and was found to have an absent uterus and a rudimentary cervix, with no introitus that could be visualised, but had normal ovaries.
Interventions: G.G underwent a Vaginoplasty that required a two doyle nasal septal splints + silicon layers to be sewn in place to form a vaginal splint, with follow up dilation therapy. H.T requires ongoing dilation therapy and ongoing psychological support to understand and come to terms with the diagnosis. Discussion/Recommendations: Primary amenorrhea should be investigated in any girl with secondary sexual characteristics who has not had menstruation by the age of 15 years or 5 years post breast development. Primary amenorrhea is usually a result of genetic or anatomical abnormalities and in some cases if left undiagnosed can lead to a life threatening event. Secondary diagnoses such as Type 1 DM and PCOS can delay a diagnosis due to higher rates of secondary amenorrhea within these subgroups; these cases hope to highlight the need for thorough investigation in all girls with a presentation of amenorrhea. Background: Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is characterized by cortisol and aldosterone deficiency and androgen excess and is divided into 2 subtypes: classic and nonclassic (NC). Depending on the degree of aldosterone deficiency, classic CAH is further subdivided into saltwasting (SW) and simple-virilizing (SV). There is some overlap in the clinical management of the classic (severe) and NC (mild) forms, although lifetime glucocorticoid therapy is not indicated for NC males. Patient Demographics: 8 y/o Caucasian male presented to our clinic for evaluation of possible CAH. Clinical Presentation: Patient presented with pubic hair and 3 year bone age advancement. Relevant Past History: Newborn screening for CAH was negative and patient had normal developmental milestones with no prior illnesses, surgeries, or hospitalizations. At age 8, he was noted to have public hair and advanced bone age. Physical examination was significant for testicular volume (4 cm 3 right, 5 cm 3 left) indicating onset of central puberty.
Relevant Family History: 13y/o sister was diagnosed with classic 21-OHD CAH following a positive newborn screen. She had mild clitoromegaly and no other genital ambiguity. She was treated with hydrocortisone and fludrocortisone from 2 weeks of age. CYP21A2 genotyping revealed mother heterozygous Q318X; father V281 L/I172N; patient V281 L/Q318x; sister I172N/Q318X. Evaluation: Early morning laboratory evaluation showed 17-hydroxyprogesterone (17-OHP) 368 ng/dL, androstenedione 59 ng/dL (31-65), plasma renin activity 1.7 ng/mL/h (0.8-2.0). ACTH stimulation test confirmed the diagnosis of NC CAH with 17-OHP 3395 ng/dL at 60 min. Interventions: Hydrocortisone 5 mg/2.5 mg/5 mg (9.5 mg/m 2 /day) and GnRH analogue were started. Nursing intervention included education to family about the various forms of CAH and emphasis on oral stress dosing and injectable hydrocortisone training to prevent adrenal crisis. Discussion/Recommendations: Our patient's phenotype and genotype were consistent with the diagnosis of NC CAH due to 21-OHD, despite his sister having classic CAH. Family genetic counseling was suggested. Treatment of classic and NC CAH includes prevention of short stature, prevention of adrenal insufficiency and management of early central puberty. Nurses should be aware of the genetic complexities of this
